ESTA (Establishment Labs Holdings) ROE % Adjusted to Book Value: -2.47% (As of Mar. 2026)


ESTA Establishment Labs Holdings Inc ESTA
75 GF Score
Price $85.81
GF Value $61.35
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Establishment Labs Holdings ROE % Adjusted to Book Value?

Establishment Labs Holdings ESTA -1.86% 75 ROE % Adjusted to Book Value is -2.47% as of Mar. 2026. GuruFocus rates ESTA with a GF Score™ of 75/100 and a GF Value™ of $61.35 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Establishment Labs Holdings's ROE % for the quarter that ended in Mar. 2026 was -279.30%. Establishment Labs Holdings's PB Ratio for the quarter that ended in Mar. 2026 was 112.88. Establishment Labs Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -2.47%.


Establishment Labs Holdings ROE % Adjusted to Book Value Related Terms


Establishment Labs Holdings ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Establishment Labs Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Establishment Labs Holdings ROE % Adjusted to Book Value Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.04 0.00 -41.88 -9.47 -1.47

Establishment Labs Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.91 -3.98 -3.13 -0.58 -2.47

ESTA vs AXGN, TMDX, BFLY: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Establishment Labs Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's ROE % Adjusted to Book Value falls into.


ESTA
75GF Score
Establishment Labs Holdings Inc ESTA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Establishment Labs Holdings ROE % Adjusted to Book Value Calculation

Establishment Labs Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-133.25% / 90.65
=-1.47%

Establishment Labs Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-279.30% / 112.88
=-2.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -2.47% mean?
Establishment Labs Holdings (ESTA) has a ROE % Adjusted to Book Value of -2.47% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Establishment Labs Holdings and its competitors.
Is Establishment Labs Holdings' ROE % Adjusted to Book Value too high?
Establishment Labs Holdings' current ROE % Adjusted to Book Value is -2.47%. Overall, Establishment Labs Holdings has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' ROE % Adjusted to Book Value compare to AXGN and TMDX?
Establishment Labs Holdings' ROE % Adjusted to Book Value of -2.47% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Establishment Labs Holdings and its competitors. Establishment Labs Holdings's current ROE % Adjusted to Book Value is -2.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (ESTA) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.35, compared to a current price of $85.81 — trading 39.9% above its estimated fair value. The current ROE % Adjusted to Book Value is -2.47%. Establishment Labs Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Establishment Labs Holdings (ESTA), the current ROE % Adjusted to Book Value is -2.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Establishment Labs Holdings (ESTA) Overvalued in 2026?

Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued. The current stock price of $85.81 is trading 39.9% above its estimated GF Value™ of $61.35. GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.

Key valuation signals for ESTA:

  • ROE % Adjusted to Book Value: -2.47%
  • GF Value™: $61.35 vs. price of $85.81 (39.9% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the ESTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Establishment Labs Holdings Business Description

Other Exchanges 3E0:Germany
Address 11401 Century Oaks Terrace, Suite 400, Austin, TX, USA, 78758
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
75GF Score

Get the complete analysis for ESTA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$85.81
Price
$61.35
GF Value